NNK administration stimulated inducible lung cancer biomarkers, including (i) ICAM-1 level, c-MYC, and MMP9 genes, (ii) inflammation, (iii) angiogenesis, and (iv) proliferation. The gene discussed is MYC; the disease is lung carcinoma.